Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
other: Body responsible for the test
Title:
Unnamed
Year:
2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Directive 84/449/EEC B5 (maximixation test) OECD 406 1981
Deviations:
not specified
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The test was performed before the REACH regulation.

Test material

Constituent 1
Reference substance name:
A mixture of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate
EC Number:
403-490-8
EC Name:
A mixture of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate
IUPAC Name:
403-490-8
Constituent 2
Reference substance name:
reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate, diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate, propylene carbonate
IUPAC Name:
reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate, diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate, propylene carbonate

In vivo test system

Test animals

Species:
guinea pig
Strain:
not specified
Sex:
not specified

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
propylene glycol
Concentration / amount:
induction:
intradermal 0.1 ml of 1% w/w in propylene glycol
epidermal: 0.5 ml of 25% w/w in propylene glycol
challenge: 0.5 ml of 25% w/w in propylene glycol
Challengeopen allclose all
Route:
other: epicutaneous
Vehicle:
propylene glycol
Concentration / amount:
induction:
intradermal 0.1 ml of 1% w/w in propylene glycol
epidermal: 0.5 ml of 25% w/w in propylene glycol
challenge: 0.5 ml of 25% w/w in propylene glycol
No. of animals per dose:
20 animals in test group
Challenge controls:
10 animals in negative control group
Positive control substance(s):
no

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
25%
No. with + reactions:
2
Total no. in group:
20
Clinical observations:
no data
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no data
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
5%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no data
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
25%
No. with + reactions:
0
Total no. in group:
2
Clinical observations:
no data
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10%
No. with + reactions:
1
Total no. in group:
20
Clinical observations:
no data
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
5%
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
no data
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
25%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no data
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
25%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no data

Any other information on results incl. tables

Maximum concentration not causing irritation in preliminary tests: 25%.


Signs of irritation during induction: 0/10


Evidence of sensitisation of each challenge concentration: 3/20


 


Other observations:


No skin reaction observed in any of the control aninals


1 animal showed scaliness in the substance treated group


 

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Remarks:
Not skin sensitizer
Conclusions:
The substance is not skin sensitising
Executive summary:

Due to the lack of information provided by ECHA, it is difficult to assess this end point fully.